Patents by Inventor Zhiqiang Zhu
Zhiqiang Zhu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11978583Abstract: A coil module includes a first planar coil winding that includes a plurality of turns of coils, at least one turn of first coil in the plurality of turns of coils includes at least one first cutting opening, and the first cutting opening divides the first coil into a first outer side part and a first inner side part along an extension direction of the coil, and a first target side part includes a first cutting groove, the first target side part is at least one of the first outer side part and the first inner side part, an extension direction of the first cutting groove is the same as an extension direction of the first target side part, and a width of a single first cutting groove is less than or equal to a width of a single first cutting opening.Type: GrantFiled: January 26, 2021Date of Patent: May 7, 2024Assignee: HUAWEI TECHNOLOGIES CO., LTD.Inventors: Yongfa Zhu, Xiaowei Chen, Tao Ding, Zhiqiang Zeng, Chang Yang, Zhaodong He
-
Publication number: 20240135874Abstract: The present application discloses a display panel and a display device. The display panel comprises pixel circuits, collecting modules and feedback modules, and the pixel circuit comprises a driving module, a data writing module and a light-emitting module; wherein the data writing module is configured to transmit a voltage output by a data signal terminal to the driving module; the driving module and the light-emitting module are electrically connected between a first power supply terminal and a second power supply terminal, and the driving module is configured to generate a driving current according to the voltage from the data signal terminal and a voltage from the first power supply terminal to drive the light-emitting module to emit light; the collecting module is configured to collect at least one of a voltage actually received by the driving module and a voltage actually received by the driving module.Type: ApplicationFiled: January 12, 2023Publication date: April 25, 2024Applicant: Xiamen Tianma Display Technology Co., Ltd.Inventors: Qingyue ZHANG, Xiaoyong LIU, Zhida ZHU, Jingxiong ZHOU, Zhiqiang XIA
-
Patent number: 11954175Abstract: Disclosed herein is an improvement to prior art feature pyramids for general object detection that inserts a simple norm calibration (NC) operation between the feature pyramids and detection head to alleviate and balance the norm bias caused by feature pyramid network (FPN) and which leverages an enhanced multi-feature selective strategy (MS) during training to assign the ground-truth to one or more levels of the feature pyramid.Type: GrantFiled: July 28, 2021Date of Patent: April 9, 2024Assignee: Carnegie Mellon UniversityInventors: Fangyi Chen, Chenchen Zhu, Zhiqiang Shen, Han Zhang, Marios Savvides
-
Publication number: 20240093443Abstract: Disclosed in the present disclosure is a double-deck multi-span bridge construction method. According to the double-deck bridge construction method of the present disclosure, construction is carried out by using a method of disassembling a support jig frame in a graded and span-separated mode, an upper chord jig frame and a lower chord jig frame can be used in a recycle manner, and construction costs are reduced. In addition, a construction period of building the support jig frame is shortened, and other construction operations can be synchronously carried out on a span in which the jig frame is disassembled, for example, fire retardant coating construction can be carried out on a mounted bridge deck after the jig frame is disassembled, and the construction period of a double-deck multi-span bridge is effectively shortened.Type: ApplicationFiled: September 23, 2021Publication date: March 21, 2024Applicant: CHINA CONSTRUCTION SCIENCE AND INDUSTRY CORPORATION LTD.Inventors: Jinglei REN, Bing SUN, Yonggang GAO, Hongyu SHEN, Shaohui ZHU, Jianguo QI, Cui LIU, Ruihua YAN, Zhiqiang HE, Longfei LI, Sijie YANG, Huaidong ZHANG, Xu CHEN, Wei JIANG, Wenbo LI, Yingwu SUN, Yuhang ZHANG
-
Publication number: 20240080116Abstract: A method for determining a quantity of passive inter-modulation sources. A quantity of passive inter-modulation sources of a multi-antenna device is obtained. An interference signal that is excited by a sounding signal and that is from a passive inter-modulation source is received. Singular value decomposition is performed on a first matrix corresponding to the interference signal. A quantity of passive inter-modulation sources is determined based on a result of the singular value decomposition. In this way, the quantity of passive inter-modulation sources of the multi-antenna device is directly determined by performing operations including signal receiving and sending and calculation of the multi-antenna device, to implement convenient, accurate, and secure detection of information about the quantity of the passive inter-modulation sources of the multi-antenna device.Type: ApplicationFiled: November 9, 2023Publication date: March 7, 2024Inventors: Zhi YANG, Qiang HUO, Yanqing ZHU, Zhiqiang ZOU
-
Publication number: 20240071029Abstract: Disclosed herein is a method of soft anchor-point detection (SAPD), which implements a concise, single-stage anchor-point detector with both faster speed and higher accuracy. Also disclosed is a novel training strategy with two softened optimization techniques: soft-weighted anchor points and soft-selected pyramid levels.Type: ApplicationFiled: January 24, 2022Publication date: February 29, 2024Inventors: Chenchen ZHU, Marios Savvides, Zhiqiang Shen, Fangyi Chen
-
Patent number: 11913963Abstract: The present invention provides a humanized antibody or antibody fragment comprising (a) a humanized light chain comprising 1) Complementarity Determining Region (CDR)-L1, the sequence of which is identical to the sequence of SEQ ID NO: 3; 2) CDR-L2, the sequence of which is identical to the sequence of SEQ ID NO: 4; and 3) CDR-L3, the sequence of which is identical to the sequence of SEQ ID NO: 5, and (b) a humanized heavy chain comprising 1) CDR-H1, the sequence of which is identical to the sequence of SEQ ID NO: 6; 2) CDR-H2, the sequence of which is identical to the sequence of SEQ ID NO: 7; and 3) CDR-H3, the sequence of which is identical to the sequence of SEQ ID NO: 8, as well as methods for treating, diagnosing, and monitoring the progression of HIT. The present invention also provides methods for assessing the antigenicity and ability to cause HIT of anionic anticoagulants.Type: GrantFiled: September 2, 2022Date of Patent: February 27, 2024Assignee: The Trustees of the University of PennsylvaniaInventors: Mark I. Greene, Douglas B. Cines, Zheng Cai, Zhiqiang Zhu
-
Publication number: 20240018237Abstract: The present invention relates to the field of treatment of diseases. Specifically, the present invention relates to an anti-ROR1 antibody or an antigen-binding fragment thereof, nucleic acid molecules for encoding same, and methods for preparing same. The anti-ROR1 antibody or the antigen-binding fragment thereof of the present invention has high specificity and high affinity for ROR1, and can effectively bind ROR1 and mediate killing of ROR1 expression cells. Therefore, the present invention further relates to a pharmaceutical composition comprising the antibody or antigen-binding fragment thereof, and a use thereof in preparation of a drug which is used for prevention and/or treatment of tumors.Type: ApplicationFiled: February 28, 2022Publication date: January 18, 2024Applicants: SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD., KLUS PHARMA INC.Inventors: Haijun TIAN, Yangde CHEN, Ying-Hua CHANG, Zhiqiang ZHU, Wenhui WU
-
Publication number: 20230265180Abstract: Provided herein are isolated antibodies or antibody fragments thereof that immunospecifically bind to platelet factor 4 (PF4). In some embodiments the isolated antibodies or antigen-binding fragments thereof comprise a light chain CDR and framework region comprising SEQ ID NO: 4 and a heavy chain CDR and framework region comprising SEQ ID NO: 10. Also provided herein are methods for treating heparin-induced thrombocytopenia (HIT) and methods for reducing the likelihood that subject will become afflicted with HIT. Further disclosed are uses of the isolated antibodies or antibody fragments in the treatment of HIT or the manufacture of compositions for the treatment of HIT.Type: ApplicationFiled: November 29, 2022Publication date: August 24, 2023Inventors: Mark I. GREENE, Zheng CAI, Zhiqiang ZHU, Douglas B. CINES
-
Publication number: 20230160908Abstract: The present invention provides a humanized antibody or antibody fragment comprising (a) a humanized light chain comprising 1) Complementarity Determining Region (CDR)-L1, the sequence of which is identical to the sequence of SEQ ID NO: 3; 2) CDR-L2, the sequence of which is identical to the sequence of SEQ ID NO: 4; and 3) CDR-L3, the sequence of which is identical to the sequence of SEQ ID NO: 5, and (b) a humanized heavy chain comprising 1) CDR-H1, the sequence of which is identical to the sequence of SEQ ID NO: 6; 2) CDR-H2, the sequence of which is identical to the sequence of SEQ ID NO: 7; and 3) CDR-H3, the sequence of which is identical to the sequence of SEQ ID NO: 8, as well as methods for treating, diagnosing, and monitoring the progression of HIT. The present invention also provides methods for assessing the antigenicity and ability to cause HIT of anionic anticoagulants.Type: ApplicationFiled: September 2, 2022Publication date: May 25, 2023Inventors: Mark I. Greene, Douglas B. Cines, Zheng Cai, Zhiqiang Zhu
-
Patent number: 11524999Abstract: Provided herein are isolated antibodies or antibody fragments thereof that immunospecifically bind to platelet factor 4 (PF4). In some embodiments the isolated antibodies or antigen-binding fragments thereof comprise a light chain CDR and framework region comprising SEQ ID NO: 4 and a heavy chain CDR and framework region comprising SEQ ID NO: 10. Also provided herein are methods for treating heparin-induced thrombocytopenia (HIT) and methods for reducing the likelihood that subject will become afflicted with HIT. Further disclosed are uses of the isolated antibodies or antibody fragments in the treatment of HIT or the manufacture of compositions for the treatment of HIT.Type: GrantFiled: May 11, 2018Date of Patent: December 13, 2022Assignee: The Trustees of the University of PennsylvaniaInventors: Mark I. Greene, Zheng Cai, Zhiqiang Zhu, Douglas B. Cines
-
Patent number: 11500245Abstract: The present application discloses a backlight module and a display device. The backlight module includes a plurality of first regions and a plurality of second regions arranged adjacently; the backlight module includes a substrate, including a light-transmitting region, in which the light-transmitting region is at least partially located in the second regions; a plurality of first light-emitting elements, arranged at a side of the substrate, in which the first light-emitting elements are located in the first regions, and the first light-emitting elements emit light along a direction perpendicular to a plane where the substrate is located; a light-guiding plate, arranged at a side of the substrate away from the first light-emitting elements, in which the light-guiding plate includes a plurality of light-supplementing portions located in the second regions; and at least one second light-emitting element, arranged at a side face of the light-guiding plate.Type: GrantFiled: March 9, 2022Date of Patent: November 15, 2022Assignee: Xiamen Tianma Microelectronics Co., Ltd.Inventors: Zhiqiang Zhu, Yaozuo Ke
-
Patent number: 11435362Abstract: The present invention provides a humanized antibody or antibody fragment comprising (a) a humanized light chain comprising 1) Complementarity Determining Region (CDR)-L1, the sequence of which is identical to the sequence of SEQ ID NO: 3; 2) CDR-L2, the sequence of which is identical to the sequence of SEQ ID NO: 4; and 3) CDR-L3, the sequence of which is identical to the sequence of SEQ ID NO: 5, and (b) a humanized heavy chain comprising 1) CDR-H1, the sequence of which is identical to the sequence of SEQ ID NO: 6; 2) CDR-H2, the sequence of which is identical to the sequence of SEQ ID NO: 7; and 3) CDR-H3, the sequence of which is identical to the sequence of SEQ ID NO: 8, as well as methods for treating, diagnosing, and monitoring the progression of HIT. The present invention also provides methods for assessing the antigenicity and ability to cause HIT of anionic anticoagulants.Type: GrantFiled: June 20, 2019Date of Patent: September 6, 2022Assignee: The Trustees of the University of PennsylvaniaInventors: Mark I. Greene, Douglas B. Cines, Zheng Cai, Zhiqiang Zhu
-
Patent number: 11312784Abstract: Disclosed herein are multifunctional antigen-binding proteins comprising at least one multifunctional recombinant protein scaffold and at least one antigen-specific binding domain. Polynucleotides encoding the multifunctional antigen-binding proteins, vectors containing the disclosed polynucleotides, and cells that have been genetically engineered to express the polynucleotide are also provided. Methods of using the multifunctional antigen-binding proteins are disclosed.Type: GrantFiled: June 16, 2017Date of Patent: April 26, 2022Assignee: The Trustees of the University of PennsylvaniaInventors: Mark I. Greene, Hongtao Zhang, Zhiqiang Zhu, Lian Lam, Zheng Cai
-
Publication number: 20200216555Abstract: Disclosed herein are multifunctional antigen-binding proteins comprising at least one multifunctional recombinant protein scaffold and at least one antigen-specific binding domain, Polynucleotides encoding the multifunctional antigen-binding proteins, vectors containing the disclosed polynucleotides, and cells that have been genetically engineered to express the polynucleotide are also provided. Methods of using the multifunctional antigen-binding proteins are disclosed.Type: ApplicationFiled: June 16, 2017Publication date: July 9, 2020Inventors: Mark I. Greene, Hongtao Zhang, Zhiqiang Zhu, Lian Lam, Zheng Cai
-
Publication number: 20200165333Abstract: Provided herein are isolated antibodies or antibody fragments thereof that immunospecifically bind to platelet factor 4 (PF4). In some embodiments the isolated antibodies or antigen-binding fragments thereof comprise a light chain CDR and framework region comprising SEQ ID NO: 4 and a heavy chain CDR and framework region comprising SEQ ID NO: 10. Also provided herein are methods for treating heparin-induced thrombocytopenia (HIT) and methods for reducing the likelihood that subject will become afflicted with HIT. Further disclosed are uses of the isolated antibodies or antibody fragments in the treatment of HIT or the manufacture of compositions for the treatment of HIT.Type: ApplicationFiled: May 11, 2018Publication date: May 28, 2020Inventors: Mark I. GREENE, Zheng CAI, Zhiqiang ZHU, Douglas B. CINES
-
Patent number: 10650486Abstract: A location of a preview image of a dynamic image is determined not to be stored in memory. A request for a frame number of at least one static image included in the dynamic image to an acquired network address is transmitted in response to determining the preview image is not stored in the memory. An issued frame number from the network address is received and the issued frame number is set as a designated frame number for the at least one static image. The at least one static image is extracted having the set designated frame number. The at least one static image is displayed having the set designated frame number as the preview image to a user.Type: GrantFiled: December 14, 2017Date of Patent: May 12, 2020Assignee: Alibaba Group Holding LimitedInventor: Zhiqiang Zhu
-
Patent number: D918899Type: GrantFiled: July 1, 2020Date of Patent: May 11, 2021Inventor: Zhiqiang Zhu
-
Patent number: D945992Type: GrantFiled: April 21, 2021Date of Patent: March 15, 2022Inventor: Zhiqiang Zhu
-
Patent number: D971207Type: GrantFiled: August 18, 2021Date of Patent: November 29, 2022Inventor: Zhiqiang Zhu